Loading clinical trials...

DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 4NCT05966064

DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD)

Fibrous Dysplasia/McCune-Albright syndrome (FD/MAS) is a rare disease, consisting of the replacement of normal bone tissue with fibrous tissue. FD lesions may be isolated in one or more bones or may b...

Lead sponsor: Natasha Appelman-Dijkstra•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Natasha Appelman-Dijkstra, MD, PhD

CONTACT

+31 625301410 n.m.appelman-dijkstra@lumc.nl

Related studies

RECRUITING

Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry

NCT03231644 · Fibrous Dysplasia, McCune Albright Syndrome, and more

COMPLETEDPhase 2

Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia

NCT05509595 · Fibrous Dysplasia Of Bone

COMPLETEDNA

Epigenetic Regulation in Fibrous Dysplasia of Bone: mirDYS Study.

NCT03838991 · Fibrous Dysplasia of Bone

COMPLETED

Treatment Protocol and Long-Term Outcomes in Craniofacial Fibrous Dysplasia

NCT06167122 · Craniofacial Fibrous Dysplasia

COMPLETED

Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities

NCT04671719 · Fibrous Dysplasia, Albright Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 29, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE4

Enrollment82

Start dateJun 2023

Last updatedJan 29, 2025

Condition

Fibrous Dysplasia McCune Albright Syndrome

Locations shown

Leiden University Medical Center

Leiden

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions